SARA HARTMAN: Open Payments
NPI 1629247796 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 97 payments from 20 companies in 2025. Trend: 2023 $2,092 · 2024 $1,962 · 2025 $1,867
Food & beverage: $1,782Education: $85
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $297 |
| UCB, Inc. | 13 | $236 |
| GENZYME CORPORATION | 6 | $168 |
| Regeneron Healthcare Solutions, Inc. | 6 | $157 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $143 |
| Organon LLC | 11 | $124 |
| Botanix SB Inc | 6 | $120 |
| Amgen Inc. | 5 | $86 |
| ABBVIE INC. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
Products named: NEMLUVIO, Bimzelx, DUPIXENT, VTAMA, SOFDRA, LIBTAYO, OTEZLA, SKYRIZI.
Industry payments across AZ — which companies pay providers there.
